Clinical trial
Genetic Markers for Focal Segmental Glomerulosclerosis
NCT00001393 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Markers for Focal Segmental Glomerulosclerosis
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 1996
- Completion date
- Not reported
- Enrollment
- 616 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focal segmental glomerulosclerosis, hiv-associated focal segmental glomerulosclerosis